These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5575634)

  • 21. Lack of reversion in triclabendazole-resistant Fasciola hepatica.
    Borgsteede FH; Moll L; Vellema P; Gaasenbeek CP
    Vet Rec; 2005 Mar; 156(11):350-1. PubMed ID: 15789649
    [No Abstract]   [Full Text] [Related]  

  • 22. Field trials of triclabendazole against mixed age infections of Fasciola hepatica in sheep and cattle.
    Stansfield DG; Lonsdale B; Lowndes PA; Reeves EW; Schofield DM
    Vet Rec; 1987 May; 120(19):459-60. PubMed ID: 3603987
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of a tribromosalan and parbendazole composition against adult Fasciola hepatica in sheep.
    Cruthers LR; James TM; Goff S
    Res Vet Sci; 1981 Jan; 30(1):122-3. PubMed ID: 6894647
    [No Abstract]   [Full Text] [Related]  

  • 24. The anthelmintic efficiency of diamphenethide against Fasciola hepatica in sheep.
    Armour J; Corba J
    Vet Rec; 1972 Aug; 91(9):211-3. PubMed ID: 5080199
    [No Abstract]   [Full Text] [Related]  

  • 25. The efficac of nitroxynil in the treatment of naturally-occurring ovine fascioliasis.
    Reid JF; Armour J; Jennings FW; Urquhart GM
    Vet Rec; 1970 Jan; 86(2):41-2. PubMed ID: 5460780
    [No Abstract]   [Full Text] [Related]  

  • 26. Triclabendazole-resistant Fasciola hepatica in southwest Wales.
    Thomas I; Coles GC; Duffus K
    Vet Rec; 2000 Feb; 146(7):200. PubMed ID: 10718597
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of diamphenethide on Fasciola hepatica at different stages of development.
    Kendall SB; Parfitt JW
    Res Vet Sci; 1973 Jul; 15(1):37-40. PubMed ID: 4778488
    [No Abstract]   [Full Text] [Related]  

  • 28. [Some pathomorphologic lesions caused by hexachlorparaxylol in Fasciola by the dehelminthization of sheep].
    Reznik GK
    Wiad Parazytol; 1968; 14(5):627-30. PubMed ID: 5753356
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of experimental Fasciola hepatica infection of sheep with rafoxanide.
    Ross DB
    Vet Rec; 1970 Jul; 87(4):110-1. PubMed ID: 5472065
    [No Abstract]   [Full Text] [Related]  

  • 30. Extension of the prepatent period of Fasciola hepatica in infected animals following treatment with triclabendazole.
    Büscher G; Bowen FL; Strong MB; Allison JR; Richards RJ
    Vet Rec; 1987 May; 120(19):460-1. PubMed ID: 3603988
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of a benzenedisulfonamide against experimental Fasciola hepatica infections in calves.
    Wyckoff JH; Bradley RE
    Am J Vet Res; 1983 Nov; 44(11):2203-4. PubMed ID: 6650967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.
    Fawcett AR
    Vet Rec; 1990 Nov; 127(20):492-3. PubMed ID: 2275087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some aspects of the pathogenesis and treatment of fascioliasis.
    Sinclair KB
    Vet Rec; 1969 May; 84(22):544-7. PubMed ID: 5816032
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of triclabendazole against Fasciola hepatica in sheep and goats.
    Wolff K; Eckert J; Schneiter G; Lutz H
    Vet Parasitol; 1983 Sep; 13(2):145-50. PubMed ID: 6685399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative anthelmintic efficiency of hexachlorophene, Bayer 9015 and subcutaneous carbon tetrachloride in an outbreak of subacute fasciolosis in sheep.
    Happich FA; Boray JC; Healy BP
    Aust Vet J; 1967 Jul; 43(7):261-4. PubMed ID: 6069700
    [No Abstract]   [Full Text] [Related]  

  • 36. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anthelmintic resistance: potential benefits of 'over-diagnosis'.
    Sargison ND; Scott PR
    Vet Rec; 2011 Jun; 168(24):646-7. PubMed ID: 21685422
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of the effective dose of an experimental intramuscular formulation against immature and adult Fasciola hepatica in sheep.
    Ibarra-Velarde F; Vera-Montenegro Y; Flores-Ramos M; Cantó-Alarcon GJ; Hernández-Campos A; Alcala-Canto Y; Castillo R
    Vet Parasitol; 2018 Aug; 260():38-44. PubMed ID: 30197011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The fasciolicidal action of "Ranide" on Fasciola hepatica in experimental infection of sheep].
    Dijkstra J; van Vliet G; Over HJ
    Tijdschr Diergeneeskd; 1973 Aug; 98(15):702-12. PubMed ID: 4737653
    [No Abstract]   [Full Text] [Related]  

  • 40. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain.
    Alvarez-Sánchez MA; Mainar-Jaime RC; Pérez-García J; Rojo-Vázquez FA
    Vet Rec; 2006 Sep; 159(13):424-5. PubMed ID: 16998003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.